Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Violaine Randrian

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 12, 2023
Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective studyCamille Evrard, Pierre Ingrand, Tristan Rochelle, et al.
Frontiers in Medicine|July 5, 2022
Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal CancerViolaine Randrian, Simon Pernot, Baptiste Sionneau, et al.
Journal of Neuro-Oncology|January 3, 2025
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factorsViolaine Randrian, Fabienne Portales, Olivier Bouché, et al.
Immunity|August 9, 2011
Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentationMaria-Isabel Yuseff, Anne Reversat, Danielle Lankar, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2021
First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre studyClaire Gallois, Emilie Hafliger, Edouard Auclin, et al.
Frontiers in Genetics|January 20, 2022
HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite InstabilityGaelle Tachon, Arnaud Chong-Si-Tsaon, Thierry Lecomte, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2020
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II studyViolaine Randrian, Antoine Adenis, Jérôme Desrame, et al.
JAMA Oncology|August 3, 2023
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical TrialJulien Taïeb, Olivier Bouche, Thierry André, et al.
The Oncologist|March 31, 2025
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2Cathy Eng, Arvind Dasari, Sara Lonardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2021
Prognostic factors of colorectal cancer patients with brain metastasesPauline Roussille, Marie Auvray, Damien Vansteene, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 12, 2023
Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective studyCamille Evrard, Pierre Ingrand, Tristan Rochelle, et al.
Frontiers in Medicine|July 5, 2022
Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal CancerViolaine Randrian, Simon Pernot, Baptiste Sionneau, et al.
Journal of Neuro-Oncology|January 3, 2025
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factorsViolaine Randrian, Fabienne Portales, Olivier Bouché, et al.
Immunity|August 9, 2011
Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentationMaria-Isabel Yuseff, Anne Reversat, Danielle Lankar, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2021
First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre studyClaire Gallois, Emilie Hafliger, Edouard Auclin, et al.
Frontiers in Genetics|January 20, 2022
HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite InstabilityGaelle Tachon, Arnaud Chong-Si-Tsaon, Thierry Lecomte, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2020
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II studyViolaine Randrian, Antoine Adenis, Jérôme Desrame, et al.
JAMA Oncology|August 3, 2023
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical TrialJulien Taïeb, Olivier Bouche, Thierry André, et al.
The Oncologist|March 31, 2025
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2Cathy Eng, Arvind Dasari, Sara Lonardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2021
Prognostic factors of colorectal cancer patients with brain metastasesPauline Roussille, Marie Auvray, Damien Vansteene, et al.
Pageof 3